64 related articles for article (PubMed ID: 21516122)
1. Sumoylation of MEL1S at lysine 568 and its interaction with CtBP facilitates its repressor activity and the blockade of G-CSF-induced myeloid differentiation.
Nishikata I; Nakahata S; Saito Y; Kaneda K; Ichihara E; Yamakawa N; Morishita K
Oncogene; 2011 Oct; 30(40):4194-207. PubMed ID: 21516122
[TBL] [Abstract][Full Text] [Related]
2. A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation.
Nishikata I; Sasaki H; Iga M; Tateno Y; Imayoshi S; Asou N; Nakamura T; Morishita K
Blood; 2003 Nov; 102(9):3323-32. PubMed ID: 12816872
[TBL] [Abstract][Full Text] [Related]
3. Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dcl3.
Khanna-Gupta A; Lopingco MC; Savinelli T; Zibello T; Berliner N; Perkins AS
Oncogene; 1996 Feb; 12(3):563-9. PubMed ID: 8637713
[TBL] [Abstract][Full Text] [Related]
4. RUNX1/EVI1, which blocks myeloid differentiation, inhibits CCAAT-enhancer binding protein alpha function.
Tokita K; Maki K; Mitani K
Cancer Sci; 2007 Nov; 98(11):1752-7. PubMed ID: 17894555
[TBL] [Abstract][Full Text] [Related]
5. The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells.
Senyuk V; Chakraborty S; Mikhail FM; Zhao R; Chi Y; Nucifora G
Oncogene; 2002 May; 21(20):3232-40. PubMed ID: 12082639
[TBL] [Abstract][Full Text] [Related]
6. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation.
Strom DK; Cleveland JL; Chellappan S; Nip J; Hiebert SW
Cell Growth Differ; 1998 Jan; 9(1):59-69. PubMed ID: 9438389
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.
Moldenhauer A; Frank RC; Pinilla-Ibarz J; Holland G; Boccuni P; Scheinberg DA; Salama A; Seeger K; Moore MA; Nimer SD
J Leukoc Biol; 2004 Sep; 76(3):623-33. PubMed ID: 15197237
[TBL] [Abstract][Full Text] [Related]
8. STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1).
de Koning JP; Soede-Bobok AA; Ward AC; Schelen AM; Antonissen C; van Leeuwen D; Löwenberg B; Touw IP
Oncogene; 2000 Jul; 19(29):3290-8. PubMed ID: 10918585
[TBL] [Abstract][Full Text] [Related]
9. The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP.
Izutsu K; Kurokawa M; Imai Y; Ichikawa M; Asai T; Maki K; Mitani K; Hirai H
Oncogene; 2002 Apr; 21(17):2695-703. PubMed ID: 11965542
[TBL] [Abstract][Full Text] [Related]
10. B-myb alters the response of myeloid precursor cells to G-CSF.
Engelhard A; Campbell K; Calabretta B
Exp Cell Res; 2000 Jan; 254(1):153-62. PubMed ID: 10623475
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and laboratory study of 4 cases of myelodysplastic syndromes with t (1;3) (p36; q21)].
Zhang MR; Liu XP; Zhang Y; Yang L; Zhou XH; Hao YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):99-102. PubMed ID: 16732963
[TBL] [Abstract][Full Text] [Related]
12. MEL1S, not MEL1, is overexpressed in myelodysplastic syndromes patients with t(1;3)(p36;q21).
Xiao Z; Zhang M; Liu X; Zhang Y; Yang L; Hao Y
Leuk Res; 2006 Mar; 30(3):332-4. PubMed ID: 16102824
[TBL] [Abstract][Full Text] [Related]
13. The distal zinc finger domain of AML1/MDS1/EVI1 is an oligomerization domain involved in induction of hematopoietic differentiation defects in primary cells in vitro.
Senyuk V; Li D; Zakharov A; Mikhail FM; Nucifora G
Cancer Res; 2005 Sep; 65(17):7603-11. PubMed ID: 16140925
[TBL] [Abstract][Full Text] [Related]
14. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation.
Kitabayashi I; Yokoyama A; Shimizu K; Ohki M
EMBO J; 1998 Jun; 17(11):2994-3004. PubMed ID: 9606182
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells.
Lahortiga I; Agirre X; Belloni E; Vázquez I; Larrayoz MJ; Gasparini P; Lo Coco F; Pelicci PG; Calasanz MJ; Odero MD
Oncogene; 2004 Jan; 23(1):311-6. PubMed ID: 14712237
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia.
Ferrara FF; Fazi F; Bianchini A; Padula F; Gelmetti V; Minucci S; Mancini M; Pelicci PG; Lo Coco F; Nervi C
Cancer Res; 2001 Jan; 61(1):2-7. PubMed ID: 11196162
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation by C-terminal binding proteins.
Chinnadurai G
Int J Biochem Cell Biol; 2007; 39(9):1593-607. PubMed ID: 17336131
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-induced myeloid differentiation is dependent on activation of the MEK/ERK pathway.
Miranda MB; Xu H; Torchia JA; Johnson DE
Leuk Res; 2005 Nov; 29(11):1293-306. PubMed ID: 16164983
[TBL] [Abstract][Full Text] [Related]
19. Functional knockout of the corepressor CtBP by the second exon of adenovirus E1a relieves repression of transcription.
Sundqvist A; Bajak E; Kurup SD; Sollerbrant K; Svensson C
Exp Cell Res; 2001 Aug; 268(2):284-93. PubMed ID: 11478854
[TBL] [Abstract][Full Text] [Related]
20. EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression.
Cattaneo F; Nucifora G
J Cell Biochem; 2008 Oct; 105(2):344-52. PubMed ID: 18655152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
